The Toronto Cannabis and Cannabinoid Research Consortium brings together researchers and trainees who are actively engaged in research on cannabis and cannabinoids at the University of Toronto and Toronto Academic Health Sciences Network
TC3 is a tri-campus, multi-institution, interdisciplinary Institutional Strategic Initiative at the University of Toronto
​
Situated at the heart of Canada’s medical research and innovation ecosystem, TC3 has the unique depth and breadth of expertise and the capacity to address almost every crucial and pressing research question related to cannabis and cannabinoids and to translate research findings into real world solutions for society
TC3 will pioneer transformative cannabis and cannabinoid research and training approaches at the convergence of disciplines
The TC3 is led by an interdisciplinary team of researchers from
3 University of Toronto campuses, 6 faculties, 11 departments and 3 hospital and research institutes
MEMBER SPOTLIGHT
A major focus of my clinical research is to investigate novel biological systems including the brain endocannabinoid system in mood and anxiety disorders as well as to explore novel treatment approaches through clinical trials with a specific interest in neurobiological and clinical effects of cannabinoids. Our lab’s current research projects include Neuroimaging / PET imaging studies evaluating the endocannabinoid system in the human brain in individuals with social anxiety disorder, healthy controls and participants using THC.
​
We are also planning a clinical pilot trial of cannabidiol in treatment of social anxiety disorder and we are currently conducting survey on cannabis use, perceptions, motivations, risks and benefits in individuals with mood and anxiety disorders, OCD and PTSD and it is planned to expand this to individuals with concurrent disorders
Dr. Stefan Kloiber
Centre for Addiction
and Mental Health
TRAINEE SPOTLIGHT
My project aims to assess the effects of cannabinoids in pain, anxiety, memory and disease stages of osteoarthritis in mice.
​
​
Cannabis is a potential therapy for osteoarthritis and may provide analgesic, anti-inflammatory, antidepressant and disease-modifying effects. The results of this work will inform drug administration protocols for planned clinical studies of cannabis for osteoarthritis pain, as well as provide unique information on the mechanisms by which cannabinoids relieve pain.
Dr. Helena Fetter Filippini
Lab of Dr. Robert Bonin
University of Toronto
FUNDERS & PARTNERS
